Skip to content
Center for Reproductive Rights
Center for Reproductive Rights

Primary Menu

  • About
    • Overview
    • Center Leadership & Staff
    • Pro Bono Program
    • Creative Council
    • Annual Reports
    • Contact Us
    • Careers
    • Diversity, Equity and Inclusion
  • Work
    • Overview
    • Litigation
    • Legal Policy and Advocacy
    • Resources & Research
    • Recent Case Highlights
    • Landmark Cases
    • World’s Abortion Laws Map
    • After Roe Fell: Abortion Laws by State
  • Issues
    • Overview
    • Abortion
    • Adolescent Sexual and Reproductive Health and Rights
    • Assisted Reproduction
    • Contraception
    • Humanitarian Settings
    • Maternal Health
    • COVID-19
  • Regions
    • Overview
    • Africa
    • Asia
    • Europe
    • Latin America and the Caribbean
    • United States
    • Global Advocacy
  • News
    • Latest News
    • Center in the Spotlight
    • Events
    • Press Releases
    • Press Room
    • Newsletters
  • Resources
    • Resources & Research
    • World Abortion Laws Map
    • After Roe Fell: Abortion Laws by State
  • Act
    • Overview
    • Give
    • Act
    • Learn
  • Donate
    • Make a Gift Now
    • Be a Champion
    • Join the Advocates Council
    • Become a Major Donor
    • Give Through Your Donor-Advised Fund
    • Make a Gift In Honor
    • Attend an Event
    • Leave a Legacy
    • More Ways to Give
  • Twitter
  • Facebook
  • Instagram
  • YouTube
  • LinkedIn
Donate
icon-hamburger icon-magnifying-glass Donate
icon-magnifying-glass-teal

U.S. Repro Watch, Feb. 15

Center for Reproductive Rights - Center for Reproductive Rights - search logo
search Close Close icon
Center for Reproductive Rights -
Menu Close Menu Close icon
Donate

Primary Menu

  • About
    • Overview
    • Center Leadership & Staff
    • Pro Bono Program
    • Creative Council
    • Annual Reports
    • Contact Us
    • Careers
    • Diversity, Equity and Inclusion
  • Work
    • Overview
    • Litigation
    • Legal Policy and Advocacy
    • Resources & Research
    • Recent Case Highlights
    • Landmark Cases
    • World’s Abortion Laws Map
    • After Roe Fell: Abortion Laws by State
  • Issues
    • Overview
    • Abortion
    • Adolescent Sexual and Reproductive Health and Rights
    • Assisted Reproduction
    • Contraception
    • Humanitarian Settings
    • Maternal Health
    • COVID-19
  • Regions
    • Overview
    • Africa
    • Asia
    • Europe
    • Latin America and the Caribbean
    • United States
    • Global Advocacy
  • News
    • Latest News
    • Center in the Spotlight
    • Events
    • Press Releases
    • Press Room
    • Newsletters
  • Resources
    • Resources & Research
    • World Abortion Laws Map
    • After Roe Fell: Abortion Laws by State
  • Act
    • Overview
    • Give
    • Act
    • Learn
  • Donate
    • Make a Gift Now
    • Be a Champion
    • Join the Advocates Council
    • Become a Major Donor
    • Give Through Your Donor-Advised Fund
    • Make a Gift In Honor
    • Attend an Event
    • Leave a Legacy
    • More Ways to Give
  • Twitter
  • Facebook
  • Instagram
  • YouTube
  • LinkedIn

Related Content

Issues:

Abortion, SRHR General

Regions:

United States

Type:

US Repro Watch, News, Story

Follow the Center

Donate Now

Join Now

02.15.2023

Abortion United States US Repro Watch

U.S. Repro Watch, Feb. 15

Nat Ray
This week's top 3 news items on U.S. reproductive rights.

Share this Story

  • facebook
  • Twitter
  • linkedin
  • Email id

“U.S. Repro Watch” provides periodic updates on news of interest on U.S. reproductive rights. Here are three recent items you won’t want to miss:

1. Texas filed a lawsuit against the Biden administration seeking to prevent it from asking pharmacies to fill reproductive health prescriptions.

  • The lawsuit targets guidance issued by the Biden Administration in July that pharmacies risk violating federal antidiscrimination law if they refuse to fill prescriptions for essential medication because of their effect on pregnancy.
  • Some pharmacies have expressed fear that they could be prosecuted in states with abortion bans for filling prescriptions for drugs that can also be used to terminate a pregnancy. One such drug is methotrexate, which is used to treat a range of chronic conditions such as rheumatoid arthritis and is also a common treatment for ectopic pregnancies.
  • Last year, Texas similarly sued the federal government over guidance requiring hospitals to provide abortion care to patients facing medical emergencies.

More on abortion laws and policies in the states.

After Roe Fell: Abortion Laws by StateAfter Roe Fell: Abortion Laws by State link

After Roe Fell: Abortion Laws by State

Explore this interactive map to learn more about each state’s abortion laws and policies, updated in real time.

2. State lawmakers are continuing efforts to restrict abortion access. . .

  • Idaho lawmakers introduced a bill that would make it harder for young people to access abortion care out of state.
  • Despite the South Carolina Supreme Court’s recent ruling striking down a six-week abortion ban as unconstitutional, the South Carolina Senate passed another six-week abortion ban. A state House committee also approved a proposal for a total ban.

. . . and protect it.

  • Minnesota lawmakers advanced legislation that would protect abortion providers and patients from legal actions by other states.
  • Maryland Gov. Wes Moore announced his support for several bills protecting abortion access, including a constitutional amendment to enshrine abortion rights introduced this week.

3. Anti-abortion members of Congress introduced resolutions seeking to deny veterans abortion care.

  • The resolutions introduced in both the House of Representatives and the Senate attacked a rule issued in September by the U.S. Department of Veterans Affairs to make abortion services available in certain cases to veterans, including in states where abortion is banned.

Learn more.

Center CEO Discusses FDA Case on MSNBCCenter CEO Discusses FDA Case on MSNBC link

Center CEO Discusses FDA Case on MSNBC

Coming Up

February 24 (new date): Briefing due in Alliance for Hippocratic Medicine v. FDA, a lawsuit that could end access to abortion medication nationwide.

  • In this case brought by anti-abortion groups seeking to have abortion medication removed from the market, the judge issued an order extending the briefing deadline to February 24—after which the court could issue its decision.

Did you know?

Research shows that mifepristone—one of two drugs used in medication abortion—is safe, effective, and used around the world. In Canada, data reaffirmed that mifepristone can safely be prescribed and dispensed like any other drug. A study from the United Kingdom found that wait times for care dropped with no difference in safety outcomes when medication abortion was provided via telemedicine.

U.S. Repro WatchU.S. Repro Watch link

U.S. Repro Watch

Read previous U.S. Repro Watch posts.

However, access to mifepristone is under threat in the U.S. Without the FDA-approved medication, millions could be left without access to abortion care. In Maine alone, where the right to abortion is protected under state law, the share of counties with an abortion provider could drop from 88% to as low as 19% without mifepristone available.

Tags: US repro watch

Related Posts

U.S. Repro Watch: 5 Items You Won’t Want to Miss

Recent news of interest on reproductive rights in the United States.

Abortion, SRHR General,United States
U.S. Repro Watch: 5 Items You Won’t Want to Miss

U.S. Repro Watch, Feb. 1

Recent news of interest on reproductive rights in the United States.

Abortion, SRHR General,United States
U.S. Repro Watch, Feb. 1

U.S. Repro Watch, Feb. 8

This week's top 5 news items on U.S. reproductive rights.

Abortion, SRHR General,United States
U.S. Repro Watch, Feb. 8

Sign up for email updates.

The most up-to-date news on reproductive rights, delivered straight to you.

Footer Menu

  • Careers
  • Privacy Policy
  • Contact Us

Center for Reproductive Rights
© (1992-2022)

Use of this site signifies agreement with our disclaimer and privacy policy.

Center for Reproductive Rights
This site uses necessary, analytics and social media cookies to improve your experience and deliver targeted advertising. Click "Options" or click here to learn more and customize your cookie settings, otherwise please click "Accept" to proceed.
OPTIONSACCEPT
Manage consent

Privacy Overview

This website uses cookies to improve your experience while you navigate through the website. Out of these, the cookies that are categorized as necessary are stored on your browser as they are essential for the working of basic functionalities of the website. We also use third-party cookies that help us analyze and understand how you use this website. These cookies will be stored in your browser only with your consent. You also have the option to opt-out of these cookies. But opting out of some of these cookies may affect your browsing experience.
Necessary
Always Enabled
Necessary cookies are absolutely essential for the website to function properly. This category only includes cookies that ensures basic functionalities and security features of the website. These cookies do not store any personal information.
Functional
Functional cookies help to perform certain functionalities like sharing the content of the website on social media platforms, collect feedbacks, and other third-party features.
Performance
Performance cookies are used to understand and analyze the key performance indexes of the website which helps in delivering a better user experience for the visitors.
Analytics
Analytical cookies are used to understand how visitors interact with the website. These cookies help provide information on metrics the number of visitors, bounce rate, traffic source, etc.
CookieDurationDescription
_ga2 yearsThis cookie is installed by Google Analytics. The cookie is used to calculate visitor, session, campaign data and keep track of site usage for the site's analytics report. The cookies store information anonymously and assign a randomly generated number to identify unique visitors.
_gat_UA-6619340-11 minuteNo description
_gid1 dayThis cookie is installed by Google Analytics. The cookie is used to store information of how visitors use a website and helps in creating an analytics report of how the wbsite is doing. The data collected including the number visitors, the source where they have come from, and the pages viisted in an anonymous form.
_parsely_session30 minutesThis cookie is used to track the behavior of a user within the current session.
HotJar: _hjAbsoluteSessionInProgress30 minutesNo description
HotJar: _hjFirstSeen30 minutesNo description
HotJar: _hjid1 yearThis cookie is set by Hotjar. This cookie is set when the customer first lands on a page with the Hotjar script. It is used to persist the random user ID, unique to that site on the browser. This ensures that behavior in subsequent visits to the same site will be attributed to the same user ID.
HotJar: _hjIncludedInPageviewSample2 minutesNo description
HotJar: _hjIncludedInSessionSample2 minutesNo description
HotJar: _hjTLDTestsessionNo description
SSCVER1 year 24 daysThe domain of this cookie is owned by Nielsen. The cookie is used for online advertising by creating user profile based on their preferences.
Advertisement
Advertisement cookies are used to provide visitors with relevant ads and marketing campaigns. These cookies track visitors across websites and collect information to provide customized ads.
CookieDurationDescription
_fbp3 monthsThis cookie is set by Facebook to deliver advertisement when they are on Facebook or a digital platform powered by Facebook advertising after visiting this website.
fr3 monthsThe cookie is set by Facebook to show relevant advertisments to the users and measure and improve the advertisements. The cookie also tracks the behavior of the user across the web on sites that have Facebook pixel or Facebook social plugin.
IDE1 year 24 daysUsed by Google DoubleClick and stores information about how the user uses the website and any other advertisement before visiting the website. This is used to present users with ads that are relevant to them according to the user profile.
IMRID1 year 24 daysThe domain of this cookie is owned by Nielsen. The cookie is used for storing the start and end of the user session for nielsen statistics. It helps in consumer profiling for online advertising.
personalization_id2 yearsThis cookie is set by twitter.com. It is used integrate the sharing features of this social media. It also stores information about how the user uses the website for tracking and targeting.
TDID1 yearThe cookie is set by CloudFare service to store a unique ID to identify a returning users device which then is used for targeted advertising.
test_cookie15 minutesThis cookie is set by doubleclick.net. The purpose of the cookie is to determine if the user's browser supports cookies.
Others
Other uncategorized cookies are those that are being analyzed and have not been classified into a category as yet.
CookieDurationDescription
adEdition1 dayNo description
akaas_MSNBC10 daysNo description
cookielawinfo-checkbox-functional1 yearThe cookie is set by GDPR cookie consent to record the user consent for the cookies in the category "Functional".
cookielawinfo-checkbox-others1 yearNo description
geoEdition1 dayNo description
next-i18next1 yearNo description
SAVE & ACCEPT
Powered by CookieYes Logo
Scroll Up